Navigation Links
FP-6500/6600 research-grade fluorescence spectrometers from JASCO

ProductsFP-6500/6600 research-grade fluorescence spectrometers from JASCO
Company JASCO
Item FP-6500/6600 research-grade fluorescence spectrometers
Price 
Description The FP-6500 is the research-grade spectrofluorometer with a minimum 1 nm resolution and a highest sensitivity S/N ratio 200 or greater for the Raman band of water.
The FP-6500 is especially designed to keep in mind in order to meet requirements in biochemistry as kinetics, stopped-flow, titration, or anisotropic measurements.
The FP-6500 is designed to keep GLP/GMP compliance in mind. Built-in low pressure Mercury lamp and UV cut filter enable to the GLP/GMP compliance with validation software which is available as standard.
The FP-6600 is a factory optional model of the FP-6500 which can be covered emission measurement of NIR region up to 1010 nm by using the holographic grating with 900 grooves/mm and R2658P photomultiplier tube for the emission monochromator.

  • Spectral Slit Width: &nsbp;1, 3, 5, 10, 20, L5, L10 nm on both EX and EM monochromators monochromator
Info JASCOJASCO
8649 Commerce Drive
Easton, MD 21601 USA

Customer Service: (410) 822-1220
Fax Number: (410) 822-7526
Web Site: http://www.jascoinc.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Terminal deoxynucleotidyl transferase (TdT) Immunofluorescence Assay Kit from AbD Serotec
2. Gel / Mount mounting medium - fluorescence from GeneTex
3. Autofluorescence Eliminator Reagent from CHEMICON
4. HV-2080-01 Column Switching Valve from JASCO
5. LV-2080 Solvent Switching Valve from JASCO
6. EZChrom Elite from JASCO
7. AS-2055/2057 Intelligent Autosampler from JASCO
8. Supercritical fluid chromatography and extraction systems (SFC/SFE) from JASCO
... ( Abpromise for all tested ... Synthetic peptide derived from within residues ... MSY2/YBOX2. (Note: the amino acid ... (Peptide available as ab27460 .) ...
Request Info...
Molecular Biology grade. Ideally suited for DNA and RNA separation and recovery. High gel strength. Gelling temp. 36C. Melting temp. 88C. EEO: 0.05-0.13 Resolution 0.2-40 kb; Rnase/Dnase: none detec...
... Signet offers the most comprehensive, ... requirements. We have incorporated unprecedented quality ... capabilities. This includes proven detection chemistries ... to the TechMate protocol. It also ...
Biology Products:
(Date:4/1/2015)... Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces the ... wallets is underway to early access pre-order customers. ... usage at retail outlets including Walmart, Target, AT&T, Dunkin, ... Wocket was accepted at all outlets and very easy ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
(Date:3/24/2015)... 24, 2015 Research and Markets ( ... "Global Iris Recognition Market 2015-2019" report to their ... Recognition market to grow at a CAGR of 23.5 ... covers the present scenario and the growth prospects of ... To calculate the market size, the report considers the ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... the next big innovation in sustainable climate technology? ... for Business Law and Regulation at Case Western Reserve ... do just that. "Technology-induced prizes have a long ... on a Climate Prize Rewarding Energy Innovation to Achieve ...
... ST. AUGUSTINE, TRINIDAD AND TOBAGOFlower color in plants ... carotenoids. Research has found that the ultimate color displayed ... also on other factors, including cell shape, presence of ... role of pH in creating color has allowed plant ...
... Ill. Researchers have identified a protein long known to ... growth. Their study, in the journal Oncogene , is ... accomplishes this feat. "People suggested that Runx3 might be ... it is down-regulated in a lot of breast cancer cell ...
Cached Biology News:CWRU law professor eyes prize-based incentives to generate climate innovation 2Engineering blue-hued flowers 2Team identifies new breast cancer tumor suppressor and how it works 2
(Date:4/21/2015)... CAMBRIDGE, Mass. , April 21, 2015 ... clinical data from a multi-arm Phase 1 study of ... data were presented in an oral session by Dr. ... Association for Cancer Research Annual Meeting in ... and tolerability of MM-141 as a monotherapy and in ...
(Date:4/21/2015)... 2015 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ... on Thursday, April 23, 4:30 p.m. ET. Participants are ... Investor call information: U.S./ ... toll number: (925) 418-7845 Participant Passcode: 32888538 ... Amirkiai , tina.amirkiai@fleishman.com . Access will ...
(Date:4/21/2015)... Calif. , April 21, 2015 /PRNewswire/ ... provider of advanced cryogenic logistics solutions for ... immunotherapies, stem cells, cell lines, clinical research ... announced that Dr. Mark W. Sawicki ... the 3rd Annual BioLogistics Summit in ...
(Date:4/21/2015)... Mass. , April 21, 2015 /PRNewswire/ ... developing transformative pharmaceutical products for subcutaneous delivery, ... pivotal trial of its investigational proprietary drug ... of edema associated with congestive heart failure. ... scPharmaceuticals is developing a proprietary patch pump.  ...
Breaking Biology Technology:First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Ampio Announces Investor Call on Thursday, April 23, 4:30 p.m. ET 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 3scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 2scPharmaceuticals Announces Start of Pivotal Trial for Novel Furosemide Solution for Subcutaneous Delivery 3